antazoline has been researched along with Pterygium in 1 studies
Antazoline: An antagonist of histamine H1 receptors.
antazoline : A member of the class of imidazolines that is 2-aminomethyl-2-imidazoline in which the exocyclic amino hydrogens are replaced by benzyl and phenyl groups. Antazoline is only found in individuals that have taken the drug.
Pterygium: An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enkvetchakul, O | 1 |
| Thanathanee, O | 1 |
| Rangsin, R | 1 |
| Lekhanont, K | 1 |
| Suwan-Apichon, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study[NCT02342392] | Phase 2/Phase 3 | 36 participants (Actual) | Interventional | 2012-09-30 | Completed | ||
| Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management[NCT01736449] | Phase 4 | 31 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for antazoline and Pterygium
| Article | Year |
|---|---|
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antazoline; Antibodies, Monoclonal, Humanized; Bev | 2011 |
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antazoline; Antibodies, Monoclonal, Humanized; Bev | 2011 |
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antazoline; Antibodies, Monoclonal, Humanized; Bev | 2011 |
A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antazoline; Antibodies, Monoclonal, Humanized; Bev | 2011 |